Effect of exogenous surfactants on in-vitro pneumocystis carinii growth

R. Escamilla, E. M. Aliouat, B. Degano, M. C. Prévost, E. Dei-Cas (Toulouse, Lille, France)

Source: Annual Congress 2001 - Unusual pulmonary infections
Session: Unusual pulmonary infections
Session type: Thematic Poster Session
Number: 2004

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Escamilla, E. M. Aliouat, B. Degano, M. C. Prévost, E. Dei-Cas (Toulouse, Lille, France). Effect of exogenous surfactants on in-vitro pneumocystis carinii growth. Eur Respir J 2001; 16: Suppl. 31, 2004

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
99mTc-DTPA lung clearance test: Role in the diagnosis of Pneumocystis carinii pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 591s
Year: 2003

Pneumocystis jirovecii
Source: Respipedia Article
Year: 2018

Pneumocystis jirovecii infection
Source: Eur Respir Monogr 2014; 66: 138-152
Year: 2014


Pneumocystis carinii pneumonia (PCP) in HIV negative patients
Source: Eur Respir J 2001; 18: Suppl. 33, 302s
Year: 2001

Pneumocystis carinii pneumonia in an otherwise healthy patient
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Evaluation of β-D-glucan, LD and KL-6 in the diagnosis and monitoring of Pneumocystis carinii pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 336s
Year: 2003

Assessement of pulmonary TB in association with pneumocystis jiroveci
Source: Annual Congress 2008 - Difficult tuberculosis cases
Year: 2008

Role of pneumocystis jiroveci in interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004

Cell-mediated immunity in patients with Pneumocystis jirovecii pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Pneumocystis carinii (jiroveci) pneumonia (PCP) in ICU patients with hematological malignancies
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004

Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues
Source: Eur Respir J 2003; 21: 204-208
Year: 2003



Usefulness of alveoloscopy in the diagnosis pf Pneumocystis jiroveci pneumonia in HIV+ patients
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Compared efficacies of lung delivery using two nebulizers in the prophylaxis against pneumocystis carinii pneumonia
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Apparent absence of pneumocystis jirovecii in healthy subjects
Source: Eur Respir J 2006; 28: Suppl. 50, 559s
Year: 2006

Clinical patterns of Pneumocystis Jirovecii in HIV and non-HIV patients
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Pneumocystis jiroveci colonisation in Turkish patients with primary pulmonary disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 411s
Year: 2005

Usefulness of measurement of serum (1®3)β-D-glucan in the diagnosis of pneumocystis jiroveci pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 559s
Year: 2006

Pulmonary embolism or Pneumocystis jiroveci pneumonia?
Source: ISSN=ISSN 1810-6838, ISBN=, page=83
Year: 2006

Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients
Source: Eur Respir J 2002; 20: 982-989
Year: 2002



Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018